approval
saveRIFATER (ISONIAZID) — FDA approval
community read0 votes
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalRIFATER (ISONIAZID) — FDA approvalDec 5, 2025 · 300d ago
- approvalRIFATER (ISONIAZID) — FDA approvalOct 8, 2025 · 358d ago
- approvalRIFATER (ISONIAZID) — FDA approvalFeb 5, 2025 · 603d ago
- approvalRIFATER (ISONIAZID) — FDA approvalOct 10, 2024 · 721d ago
- approvalRIFATER (ISONIAZID) — FDA approvalDec 8, 2023 · 1028d ago
- approvalRIFATER (ISONIAZID) — FDA approvalAug 16, 2023 · 1142d ago
- approvalRIFATER (ISONIAZID) — FDA approvalFeb 10, 2023 · 1329d ago
- approvalRIFATER (ISONIAZID) — FDA approvalJan 29, 2022 · 1706d ago
same company · ±60 days · 6
- approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalJun 17, 2021
- approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalJun 17, 2021
- approvalToujeo LA: SOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalJul 28, 2021
- approvalADLYXIN: ADLYXIN (LIXISENATIDE) — FDA approvalJul 30, 2021
- approvalteriflunomide: AUBAGIO (TERIFLUNOMIDE) — FDA approvalApr 30, 2021
- approvalteriflunomide: AUBAGIO (TERIFLUNOMIDE) — FDA approvalApr 30, 2021
comments(0)
5-min edit window · permanent after that